Results 241 to 250 of about 657,904 (378)

INTRAGRAFT EXPRESSION OF TRANSFORMING GROWTH FACTOR-BETA 1 BY A NOVEL QUANTITATIVE REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION ELISA IN LONG LASTING KIDNEY RECIPIENTS1

open access: bronze, 2000
Valeria Mas   +7 more
openalex   +1 more source

Dual‐Locking the SARS‐CoV‐2 Spike Trimer: An Amphipathic Molecular “Bolt” Stabilizes Conserved Druggable Interfaces for Coronavirus Inhibition

open access: yesAdvanced Science, EarlyView.
A new amphipathic molecule, S416 is discovered, that locks the SARS‐CoV‐2 spike protein in its closed state, blocking viral entry. S416 acts as a molecular bolt, binding six sites: three between adjacent RBDs and three connecting NTDs to RBDs. This dual‐locking mechanism stiffens the spike structure and reduces its flexibility.
Shiliang Li   +21 more
wiley   +1 more source

The value of thoracic computed tomography scan comparing to reverse transcription-polymerase chain reaction for the diagnosis of COVID-19. [PDF]

open access: yesJ Res Med Sci, 2021
Adibi A   +7 more
europepmc   +1 more source

Footprinting of DNA-binding proteins in intact cells [PDF]

open access: yes, 1993
Becker, Peter B.   +3 more
core   +1 more source

Leucine‐Rich Repeat‐Containing G Protein‐Coupled Receptor 6 Ameliorates Pressure Overload‐Induced Cardiac Hypertrophy by Regulating Cardiomyocyte Metabolic Reprogramming

open access: yesAdvanced Science, EarlyView.
LGR6 overexpression ameliorates cardiac hypertrophy by regulating metabolic reprogramming through USP4‐PPARα pathway. Abstract Metabolic reprogramming is a pivotal mechanism in the pathogenesis of pathological cardiac hypertrophy. Leucine‐rich repeat‐containing G protein‐coupled receptor 6 (Lgr6) has emerged as a significant player in cardiovascular ...
Mengmeng Zhao   +7 more
wiley   +1 more source

Strategies to Overcome Erroneous Outcomes in Reverse Transcription-Polymerase Chain Reaction (RT-PCR) Testing: Insights From the COVID-19 Pandemic. [PDF]

open access: yesCureus
Sajal SSA   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy